Perbedaan Bank Central Asia Tbk dan UBC Medical Indonesia Tbk.: Bank Central Asia Tbk diperdagangkan di Rp6.225 (kapitalisasi pasar 753,61 T, volume 24 jam 180,06 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 1,44 jt). Perbedaan utamanya: Bank Central Asia Tbk jauh lebih besar — sekitar 1289,1× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Bank Central Asia Tbk lebih aktif diperdagangkan (180,06 jt vs 1,44 jt). Mana yang lebih baik tergantung tujuan investasimu.
| BBCA | LABS | |
|---|---|---|
Kapitalisasi Pasar | 753,61 T | 584,6 M |
Volume | 180,06 jt | 1,44 jt |
Lot | 1,8 jt | 14,4 rb |
Perputaran | 1,11 T | 209,72 jt |
Harga Rata-rata | 6.176,89 | 145,64 |
Nilai Transaksi | 1,11 T | 209,72 jt |
Harga Ekuilibrium Indikatif | 6.225 | 146 |
Volume Ekuilibrium Indikatif | 292,85 rb | 753 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Selengkapnya di halaman BBCA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →